CLASS III Drug recall · Reported 14 Feb 2018 · FDA Enforcement Report

Megestrol Acetate Oral Suspension, USP 400 mg/ UD cups in boxes recalled

Mckesson Packaging Services is recalling Megestrol Acetate Oral Suspension, USP 400 mg/ UD cups in boxes, distributed nationwide in the US. The recall was initiated on 29 Jan 2018 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 0114588, Exp 10/18
Quantity recalled24120 cups

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0338-2018
FDA event ID
79060
Recalling firm
Mckesson Packaging Services, Concord, NC
Classification
Class III
Status
Terminated
Recall initiated
29 Jan 2018
FDA classified
8 Feb 2018
Reported
14 Feb 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

29 Jan 2018Recall initiated by company
8 Feb 2018Classified by FDA+10 days
14 Feb 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: Out of specification for assay (stability testing)

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist. By McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51

Where it was distributed

U.S.A. Nationwide

Nationwide

Questions about this recall

Is Megestrol Acetate Oral Suspension, USP 400 mg/ UD cups in boxes recalled?

Yes. Mckesson Packaging Services recalled Megestrol Acetate Oral Suspension, USP 400 mg/ UD cups in boxes on 29 Jan 2018. The recall is Class III and its status is Terminated. Recall number D-0338-2018.

Why was it recalled?

Subpotent Drug: Out of specification for assay (stability testing)

Which lots are affected?

Lot #: 0114588, Exp 10/18

Where was it sold?

U.S.A. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Mckesson Packaging Services

All 17

Other Megestrol recalls

All 4